Synthetic DNA Vaccine Shows Promise for Cancer Immunotherapy
Older Melanoma Patients Have Better Response to Immune Checkpoint Blockade Therapy
Novel Combination Therapy Effective for NRAS Mutant and Therapy Resistant Melanoma
Novel DNA Vaccine Design Improves Chances of Inducing Anti-Tumor Immunity
Mechanism of an Effective MEK Inhibitor Identified
Understanding the effects of certain targeted therapies on antitumor immunity is necessary to design combined interventions for more effective cancer treatment. In the past, data have shown that trametinib, an FDA-approved MEK inhibitor routinely administered to patients with melanoma and currently being studied to treat a number of other types of cancer, inhibits T cell…